Table 1.

Baseline characteristics, stratified by clinically defined UA groupsa

CharacteristicUA Groups (mg/dl)P for Trend
<7.07.0 to 9.0>9.0
Sample size (n)19,4661821188
GFR (ml/min per 1.73 m2; mean ± SD)100 ± 2093 ± 1790 ± 26<0.01
Male gender (%)55.4079.0093.60<0.01
Age (yr)42.2 ± 12.045.5 ± 12.148.8 ± 12.4<0.01
Waist circumference (cm)82 ± 1191 ± 1195 ± 12<0.01
Triglycerides (mg/dl)113 ± 58176 ± 69256 ± 99<0.01
HDL (mg/dl)62 ± 1651 ± 1348 ± 12<0.01
Fasting serum glucose (mg/dl)86 ± 1293 ± 13100 ± 17<0.01
MAP (mmHg)95 ± 10101 ± 10107 ± 11<0.01
Antihypertensive drug use (%)2.946.428.51<0.01
β Blocker (%)1.553.293.72
ACEI (%)0.972.472.13
Calcium antagonist (%)0.310.440.53
Diuretic (%)0.110.222.13
Alcohol consumption
    >3 drinks/wk (%)13.4014.5015.400.11
    ≤3 drinks/wk (%)86.6085.5084.60
Proteinuria (≥ +) (%)8.307.509.000.46
  • a ACEI, angiotensin-converting enzyme inhibitor.